Related references
Note: Only part of the references are listed.Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research
Lauren M. Hurwitz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement
Veronika W. Skrivankova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization
Verena Zuber et al.
NATURE COMMUNICATIONS (2020)
A robust and efficient method for Mendelian randomization with hundreds of genetic variants
Stephen Burgess et al.
NATURE COMMUNICATIONS (2020)
The opportunity in African genome resource for precision medicine
Segun Fatumo
EBIOMEDICINE (2020)
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
Aurora Perez-Cornago et al.
BRITISH JOURNAL OF CANCER (2020)
PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations
Mihir A. Kamat et al.
BIOINFORMATICS (2019)
Association between Liver Fibrosis and Serum PSA among US Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010
Anqi Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
Charleen D. Adams et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
Michael B. Boffa et al.
NATURE REVIEWS CARDIOLOGY (2019)
Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood
Timothy R. Rebbeck
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
James Yarmolinsky et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
IFNL4-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer
Wei Tang et al.
CLINICAL CANCER RESEARCH (2018)
The role of lipoprotein (a) in chronic kidney disease
Jemma C. Hopewell et al.
JOURNAL OF LIPID RESEARCH (2018)
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
Marie Verbanck et al.
NATURE GENETICS (2018)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
The Epidemiology of Prostate Cancer
Claire H. Pernar et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies A Mendelian Randomization Analysis
Stephen Burgess et al.
JAMA CARDIOLOGY (2018)
Understanding the Assumptions Underlying Instrumental Variable Analyses: a Brief Review of Falsification Strategies and Related Tools
Jeremy Labrecque et al.
CURRENT EPIDEMIOLOGY REPORTS (2018)
Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy
Jessica M. B. Rees et al.
STATISTICS IN MEDICINE (2017)
Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort
Verena Andrea Katzke et al.
BMC MEDICINE (2017)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Current therapies for lowering lipoprotein (a)
Julian C. van Capelleveen et al.
JOURNAL OF LIPID RESEARCH (2016)
Lipoprotein (a): impact by ethnicity and environmental and medical conditions
Byambaa Enkhmaa et al.
JOURNAL OF LIPID RESEARCH (2016)
Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies
Philip C. Haycock et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Contrasting the Genetic Architecture of 30 Complex Traits from Summary Association Data
Huwenbo Shi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
PhenoScanner: a database of human genotype-phenotype associations
James R. Staley et al.
BIOINFORMATICS (2016)
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
Florian Kronenberg
CARDIOVASCULAR DRUGS AND THERAPY (2016)
Apolipoproteins, lipids and risk of cancer
Signe Borgquist et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Structure, function, and genetics of lipoprotein (a)
Konrad Schmidt et al.
JOURNAL OF LIPID RESEARCH (2016)
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney et al.
LANCET (2016)
Blood lipids and prostate cancer: a Mendelian randomization analysis
Caroline J. Bull et al.
CANCER MEDICINE (2016)
Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
Mark A. Moyad
ASIAN JOURNAL OF ANDROLOGY (2015)
Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies
Liu YuPeng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome
Stephen Burgess
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Stephen Burgess et al.
GENETIC EPIDEMIOLOGY (2013)
Lipoprotein(a): resurrected by genetics
F. Kronenberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
Teemu J. Murtola et al.
PLOS ONE (2012)
Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Dipika Bansal et al.
PLOS ONE (2012)
Use of Mendelian randomisation to assess potential benefit of clinical intervention
Stephen Burgess et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Apolipoproteins: metabolic role and clinical biochemistry applications
Marek H. Dominiczak et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2011)
The influence of hepatic function on prostate cancer outcomes after radical prostatectomy
L. L. Banez et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Serum Creatinine and Prostate Cancer Risk in a Prospective Study
Stephanie J. Weinstein et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Elizabeth A. Platz et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Association between plasma cholesterol and prostate cancer in the PSA era
Elizabeth A. Platz et al.
INTERNATIONAL JOURNAL OF CANCER (2008)